How often should I retest my blood biomarkers?

Short answer: It depends on which biomarker, your health status, whether you started or changed a treatment, and whether the result was abnormal. Below are practical retesting intervals for common blood tests and when to test sooner.

General rules

• Get a baseline panel once if you’re previously healthy so future changes can be compared.
• Retest sooner after any new medication, new diagnosis, new symptom, or a big lifestyle change (weight loss, starting exercise, new diet).
• Repeat any abnormal result to confirm before making major decisions (often 2–12 weeks depending on the test).
• After results stabilize, move to a maintenance schedule based on risk.

Typical retesting intervals (healthy adults unless noted)

• Lipid panel (total cholesterol, LDL, HDL, triglycerides)
  • On no lipid drug and low cardiovascular risk: every 4–6 years (USPSTF). Many clinicians recheck annually.
  • After starting/changing a statin: recheck 4–12 weeks, then every 3–12 months until stable, then annually.
• HbA1c / diabetes monitoring
  • Diabetes: every 3 months until controlled, then every 3–6 months.
  • Prediabetes: every 6–12 months.
  • Low risk/normal: screening per guidelines (e.g., every 3 years for age ≥45 or sooner if risk factors).
• Basic metabolic panel (kidney function, electrolytes, glucose)
  • Annually if stable; sooner if on ACE inhibitors/ARBs, diuretics, or with kidney disease (weeks to months).
• Liver enzymes (AST/ALT)
  • If normal: annually or per provider.
  • If elevated: repeat in 2–12 weeks and evaluate cause.
  • If on potentially hepatotoxic meds: follow drug-specific schedule (often monthly at start).
• Complete blood count (CBC)
  • Annually if normal.
  • If on drugs that can cause cytopenias (chemotherapy, methotrexate), follow drug protocol (often every 1–4 weeks initially).
• Thyroid (TSH ± free T4)
  • If stable on therapy: check ~6–12 months.
  • After dose change: check ~6–8 weeks (TSH takes weeks to change).
• Vitamin D (25‑OH)
  • After starting supplementation: recheck in 8–12 weeks, then every 6–12 months if maintaining dose.
• Ferritin/iron studies
  • After iron treatment: recheck in ~2–3 months to confirm repletion.
• hs‑CRP or inflammatory markers
  • If used for risk assessment, repeat once to confirm (separated by ≥2 weeks). Not routinely repeated frequently.
• PSA
  • Follow shared decision-making based on age/risk; if tested, frequency commonly 1–4 years.
• Specialized tests (hormones, testosterone)
  • Timing matters (e.g., testosterone often tested morning); repeat after treatment changes per specialist (usually weeks to months).

When to test right away

• New symptoms (unexplained fatigue, weight change, jaundice, bleeding, infection signs).
• Abnormal previous test that could indicate serious disease.
• After starting/changing medications with known effects on labs.

Practical tips

• Ask whether the test needs fasting or a morning draw.
• Confirm whether repeat testing should be fasting or timed (e.g., morning testosterone, fasting lipids historically).
• Don’t over-test: too-frequent repeats for stable, normal results rarely change management and may cause anxiety.

Where to get tests (brands/services)

• Quest Diagnostics or LabCorp — widely used clinical labs, usually accepted by insurance, good for physician-ordered testing.
• One Medical or your primary care clinic — convenient for coordinating testing and interpretation.
• Everlywell or LetsGetChecked — convenient, CLIA‑approved at‑home kits for some common tests (lipids, HbA1c, vitamin D); good for convenience but check if your provider prefers standard lab.
• InsideTracker — for deeper, consumer-focused analytics and personalized recommendations if you want extra interpretation and lifestyle guidance.
• Dexcom (CGM) or Freestyle Libre — for continuous glucose monitoring if you or your clinician think frequent glucose tracking is needed (mostly for diabetes or metabolic research).

Bottom line: make a plan with your clinician. A typical approach: baseline panel, repeat 4–12 weeks after any new medication or major intervention, then move to annual or risk-based intervals once stable. If you want, tell me which specific biomarkers or health conditions you’re concerned about and I’ll give a tailored schedule.